Clin2
NCT04416178Possibly a fitRecruiting

Survey and interviews for families affected by sickle cell disease

Sickle Cell Disease

Part of Blood & lymphatic, Genetic & congenital clinical trials.

This study collects feedback through surveys, interviews, and focus groups from people affected by sickle cell disease. Your input helps the research team improve how genomic and gene-therapy information and needs are understood for patients and caregivers.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
352 people
Ages
13 years and older
Study type
Observational

Who can take part

  • You’re a parent/guardian (or the participant if you’re an adult) of a child or teen with sickle cell genotypes like HbSS, HbSC, or HbS with thalassemia
  • Your child’s age is about 12 months to 18 years at the start (with group-specific age cutoffs)
  • You can participate in English (you must be able to speak English fluently)
  • A parent/guardian must be able and willing to sign written consent (and teens must assent)
  • You should be well enough to safely participate—no issues that would make study participation unsafe (for example, certain severe health or cognitive concerns)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05810181Recruiting
Interviews to improve choices about gene therapy for rare diseases

This study uses one-on-one interviews to learn what families and clinicians need to make decisions about gene therapy for rare diseases. The goal is to create or improve decision tools that make gene therapy information easier to understand and act on.

Memphis, Tennessee
NCT02824471Recruiting
Testing a chip technology for sickle cell samples

This trial tests a “biochip” device using samples from people with sickle cell disease. If it works, it may help doctors study sickle cell biology more accurately using patient samples.

Cleveland, Ohio
NCT07000318Not yet recruiting· Early Phase 1
CS-206 for sickle cell disease in teens

This trial tests a new treatment called CS-206 for adolescents with severe sickle cell disease. It aims to see if this treatment can help by making stem cell transplants safer and more effective for people who have not done well with standard care.

Shanghai, Shanghai Municipality
NCT05170412Recruiting
Diet habits study for adults with sickle cell disease

This study asks adults with sickle cell disease about what they eat and their eating routines. The goal is to understand diet patterns in sickle cell and how they may relate to health, which could help future care and guidance.

Bethesda, Maryland
NCT03786549Recruiting
Sickle cell care transition program for teens and families

This study tests a structured program to help teens with sickle cell disease smoothly transition from pediatric care to adult care, with support for parents or legal guardians. It may help families coordinate care sooner and more confidently during this change.

Fort-de-France-La Martinique, La Martinique
NCT03327428Recruiting
Registry study for people with sickle cell disease

This study is a registry that collects information about people living with sickle cell disease. It may help researchers better understand sickle cell types in Germany, Austria, and Switzerland and support future research and care.

Heidelberg, Baden-Wurttemberg

Hear when a new Sickle Cell Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.